News

Flotek Advances Custody Transfer with Revolutionary Tech

Flotek Advances Custody Transfer with Revolutionary Tech

Flotek's Innovative Milestone in Natural Gas Measurement

Flotek Industries, Inc. (NYSE: FTK) has reached an extraordinary milestone in the measurement of natural gas with its XSPCT optical spectrometer. This ground-breaking technology is the first of its kind to meet the exacting standards of GPA 2172 for custody transfer in the oil and gas industry. This advancement promises to provide enhanced volume and quality data, fostering greater transparency for royalty owners, operators, and midstream companies compared to older methodologies.

Key Benefits of the XSPCT Optical Spectrometer

The XSPCT has been designed with cutting-edge technology to facilitate accurate measurements quickly. This instrument helps enhance the efficiency of gas measurement, ensuring better data collection and serving as a stepping stone toward more reliable industry practices.

Validated Accuracy and Customer Adoption

In recent tests conducted in South Texas's Eagle Ford region, five XSPCT units demonstrated impressive results, consistently surpassing a remarkable 95% pass rate for methane, ethane, propane, and higher hydrocarbons, thereby meeting or exceeding the GPA 2261 standards for reproducibility. This historical achievement marks a significant leap forward in custody transfer technology.

Revolutionizing Custody Transfer Processes

The hallmark of the XSPCT is its capability as the first optical spectrometer to achieve compliance with GPA 2172 standards. This transformation in custody transfer operations introduces real-time delivery of gas quality and volume data, minimizing the margin of error previously associated with traditional methods.

Field Trials and Reliability of the XSPCT

Extensive field trials spanning nine months and covering three major U.S. basins involved over 12 XSPCT units, showcasing an astonishingly low bias of 0.3 BTU/scf. This near negligible deviation emphasizes the remarkable precision and reliability offered by this state-of-the-art technology when compared to conventional gas chromatography systems.

Cost-Effective Solutions through Real-Time Analysis

Real-time analytics every 15 seconds drastically improves decision-making, significantly reducing costs associated with traditional gas measurement practices, which could involve infrequent sampling. Such advancements empower companies to streamline their gas quality assessments while optimizing overall operations.

Industry Adoption and Client Feedback

Endorsements from industry leaders further bolster the XSPCT's credentials. Two top-tier companies—a leading Exploration & Production (E&P) operator and a midstream partner—have successfully tested and validated the capabilities of the XSPCT for digital custody transfer valuation. This endorsement accentuates the technology's role as a game changer within the industry.

Transformative Potential for the Energy Sector

CEO Ryan Ezell expressed confidence in the XSPCT's accuracy and real-time capabilities, stating, "This technology facilitates a more transparent and data-driven valuation system, enhancing operational efficiencies for royalty owners, operators, and purchasers. The XSPCT stands as a key tool in the evolving landscape of energy management."

Overview of Flotek Industries, Inc.

Flotek Industries, Inc. is at the forefront of chemistry and data technology, specializing in innovation within the energy sector. The company develops solutions that harness real-time data to optimize customer outcomes. Boasting over 130 patents and two decades of both field and laboratory data, Flotek operates in more than 59 countries worldwide.

Committed to sustainability and minimizing energy's environmental footprint, Flotek collaborates to implement optimized chemistry and data solutions that are beneficial for land, air, and water. For more information on Flotek’s advancements and commitment to innovative solutions in the energy industry, visit their website.

Frequently Asked Questions

What is the significance of the XSPCT optical spectrometer?

The XSPCT is notable for being the first optical spectrometer to meet GPA 2172 standards, ensuring higher accuracy in natural gas measurement and custody transfer processes.

How does the XSPCT improve measurement frequency?

It provides real-time measurement every 15 seconds, which is a significant improvement over traditional methods that often rely on infrequent sampling.

What were the results of the field tests for the XSPCT?

The field tests showed that the XSPCT units had a negligible bias of just 0.3 BTU/scf, indicating a high level of reliability compared to traditional methods.

Who has validated the XSPCT technology?

Two industry-leading companies, including an E&P operator and a midstream firm, have successfully tested and approved the XSPCT for use, reinforcing its impact on the industry.

What is the mission of Flotek Industries, Inc.?

Flotek aims to provide innovative chemistry and data solutions for the energy industry while prioritizing sustainability and reducing its environmental impact.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 68

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Amgen Q3 2026 Results: What Investors Should Know

Updated Category News Views 93

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

Continue Reading
Royce Global Trust: Insights on RGT's Performance

Updated Category News Views 80

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 54

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
BD's New Liverty™ TIPS Stent: A Game Changer?

Updated Category News Views 75

Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 73

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading